Evidence map›Paper›PMID 34307123›Full record

ReviewFrontiers in oncology2021

Diagnostic Utility of Radiomics in Thyroid and Head and Neck Cancers.

Maryam Gul, Kimberley-Jane C Bonjoc, David Gorlin, Chi Wah Wong, Amirah Salem, Vincent La, Aleksandr Filippov, Abbas Chaudhry, Muhammad H Imam, Ammar A Chaudhry

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. MRI-based deep learning radiomics in predicting histological differentiation of oropharyngeal cancer: a multicenter cohort study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maryam GulAmaze Research Foundation, Department of Biomarker Discovery, Anaheim, CA, United States.
Kimberley-Jane C BonjocDepartment of Diagnostic and Interventional Radiology, City of Hope National Medical Center, Duarte, CA, United States.
David GorlinDepartment of Diagnostic and Interventional Radiology, City of Hope National Medical Center, Duarte, CA, United States.
Chi Wah WongDepartment of Diagnostic and Interventional Radiology, City of Hope National Medical Center, Duarte, CA, United States.
Amirah SalemDepartment of Diagnostic and Interventional Radiology, City of Hope National Medical Center, Duarte, CA, United States.
Vincent LaDepartment of Diagnostic and Interventional Radiology, City of Hope National Medical Center, Duarte, CA, United States.
Aleksandr FilippovDepartment of Diagnostic and Interventional Radiology, City of Hope National Medical Center, Duarte, CA, United States.
Abbas ChaudhryAmaze Research Foundation, Department of Biomarker Discovery, Anaheim, CA, United States.
Muhammad H ImamFlorida Cancer Specialists, Department of Oncology, Orlando, FL, United States.
Ammar A ChaudhryDepartment of Diagnostic and Interventional Radiology, City of Hope National Medical Center, Duarte, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiomics is an emerging field in radiology that utilizes advanced statistical data characterizing algorithms to evaluate medical imaging and objectively quantify characteristics of a given disease. Due to morphologic heterogeneity and genetic variation intrinsic to neoplasms, radiomics have the potential to provide a unique insight into the underlying tumor and tumor microenvironment. Radiomics has been gaining popularity due to potential applications in disease quantification, predictive modeling, treatment planning, and response assessment - paving way for the advancement of personalized medicine. However, producing a reliable radiomic model requires careful evaluation and construction to be translated into clinical practices that have varying software and/or medical equipment. We aim to review the diagnostic utility of radiomics in otorhinolaryngology, including both cancers of the head and neck as well as the thyroid.

Indexed as

head and neck cancerimaging biomakersimmunotherapy resistanceradiomicsthyroid cancer

Identifiers

PMID34307123
PMCPMC8293690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.